The classic website will no longer be available as of June 25, 2024. Please use the modernized ClinicalTrials.gov.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast Cancer (POSITIVE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02308085
Recruitment Status : Active, not recruiting
First Posted : December 4, 2014
Last Update Posted : April 23, 2024
Sponsor:
Collaborators:
Alliance for Clinical Trials in Oncology
Canadian Cancer Trials Group
Breast International Group
Information provided by (Responsible Party):
ETOP IBCSG Partners Foundation

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : December 2025
Estimated Study Completion Date : December 2028
Publications:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):